Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice

Journal of Ethnopharmacology

Volumn 111, Issue 2, 2007, Pages 219-226

  Zhu, Xiao Ling ^a   Chen, Alex F ^b   Lin, Zhi Bin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cyclophosphamide; Cytotoxicity; Ganoderma lucidum (Leyss. ex Fr.) Karst. (Ling Zhi); Immunomodulation; Polysaccharide

Indexed keywords

CYCLOPHOSPHAMIDE; GANODERMA LUCIDUM POLYSACCHARIDE; LEVAMISOLE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MEGADOSE; EFFECTOR CELL; ERYTHROCYTE; GANODERMA LUCIDUM; IMMUNOCOMPETENT CELL; IMMUNOPOTENTIATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LEUKOCYTE; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; MACROPHAGE; MALE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PHAGOCYTOSIS; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; CYCLOPHOSPHAMIDE; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ERYTHROCYTE COUNT; ERYTHROCYTES; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LEUKOCYTES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MITOGENS; PHAGOCYTOSIS; POLYSACCHARIDES; REISHI; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

GANODERMA LUCIDUM; MUS;

EID: 34047184387     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.11.013     Document Type: Article

References (44)

1. Bagga A., and Hari P. Levamisole-induced vasculitis. Pediatric Nephrology 14 (2000) 1057-1058
2. Ballas Z.K. Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclephosphamide. The Journal of Immunology 137 (1986) 2380-2384
3. Balow J.E., Hurley D.L., and Fauci A.S. Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. Journal Clinical Investigation 56 (1975) 65-70
4. Bao X.F., Wang X.S., Dong Q., Fang J.N., and Li X.Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59 (2002) 175-181
5. Bear H.D. Tumor specific suppressor T-cells which inhibit the in vitro generation of cytolytic T cells from immune and early tumor bearing host spleens. Cancer Research 46 (1986) 1805-1812
6. Berrebi D., Bruscoli S., Cohen N., Foussat A., Migliorati G., Bouchet-Delbos L., Maillot M.C., Portier A., Couderc J., Galanaud P., Peuchmaur M., Riccardi C., and Emilie D. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101 (2003) 729-738
7. Brutkiewicz R.R., and Sriram V. Natural killer T (NKT) cells and their role in antitumor immunity. Critical Review Oncology/Hematology 41 (2002) 287-298
8. Cao L.Z., and Lin Z.B. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunology Letters 83 (2002) 163-169
9. Cox Jr. L.A. A biomathematical model of cyclophosphamide hematotoxicity. Journal of Toxicology and Environmental Health. Part A 61 (2000) 501-510
10. Gao Y., Zhou S., Jiang W., Huang M., and Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunological Investigations 32 (2003) 201-215
11. Gao Y.H., Tang W.B., Dai X.H., Gao H., Chen G.L., Ye J.X., Chan E., Koh H.L., Li X.T., and Zhou S.F. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. Journal of Medicinal Food 8 (2005) 159-168
12. Gazit Z., and Kedar E. Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice. Cancer Immunology, Immunotherapy 38 (1994) 243-252
13. Grohn P., Heinonen E., Klefstrom P., and Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 54 (1984) 670-674
14. Hoover S.K., Barrett S.K., Turk T.M.T., Lee T.C., and Bear H.D. Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity. Cancer Immunology Immunotherapy 31 (1990) 121-127
15. Hou G., Cao R., and Xin X. Study of Ganoderma lucidum polysaccharide on the antitumor activities and immunoregulation. Korean Journal of Pharmacognosy 26 (1995) 187-192
16. Huang M., Gao Y., Tang W., Dai X., Gao H., Chen G., Ye J., Chan E., and Zhou S. Immune Responses to Water-Soluble Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) P. Karst. Polysaccharides in patients with advanced colorectal cancer. International Journal of Medicinal Mushrooms 7 (2005) 525-538
17. Joly C., Palisse M., Ribbe D., De Calmes O., and Genevey P. Acute levamisole poisoning. Presse Medicale 27 (1998) 717
18. Lei L.S., and Lin Z.B. Antagonistic effect of Ganoderma lucidum polysaccharides on the immunosuppressive response induced by cicloporin A, hydrocortisone and antitumor agents. Chinese Journal of Pharmacology and Toxicology 7 (1993) 183-185
19. Li Q., Minami M., and Inagaki H. Acute and subchronic immunotoxicity of p-chloronitrocenzene in mice. I. Effect on natural killer, cytotoxic T lymphocyte activities and mitogen-stimulated lymphocyte proliferation. Toxicology 127 (1998) 223-232
20. Li Q., Hirata Y., Piao S., and Minami M. Immunotoxicity of N,N-diethylaniline in mice: effect on natural killer activity, cytotoxic T lymphocyte activity, lymphocyte proliferation response and cellular components of the spleen. Toxicology 150 (2000) 179-189
21. Lin Z.B. Modern Research of Ganoderma lucidum. 2nd ed. (2001), Beijing Medical University Press, Beijing Chapter 1
22. Lin Z.B., and Zhang H.N. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacologica Sinica 25 (2004) 1387-1395
23. Lin S., Wang S., Lin Z., and Lin Y. Isolation and identification of active components of Ganoderma lucidum cultivated with grass and wood log I. Extraction, purification and characterization of glycopeptide. Chinese Traditional and Herbal Drugs 34 (2003) 872-874
24. Marcinkiewicz J., Bryniarski K., and Ptak W. Cyclophosphamide uncovers two separate macrophage subpopulations with opposite immunogenic potential and different patterns of monokine production. Cytokine 6 (1994) 472-477
25. Maruoka H., Ikarashi Y., Shinohara K., Miyata M., Sugimura T., Terada M., and Wakasugi H. A novel monoclonal antibody permitting recognition of NKT cells in various mouse strains. Biochemical and Biophysical Research Communications 242 (1998) 413-418
26. Masnaya N.V., and Ratner G.M. Peculiarities of primary humoral immune response in mice with cytostatic disease. Bulletin of Experimental Biology and Medicine 129 (2000) 370-373
27. Morato E.F., Gerbase-DeLima M., and Gorczynski R.M. Conditioned immunosuppression in orally immunized mice. Brain, Behavior, and Immunity 10 (1996) 44-54
28. Moynihan J., and Cohen N. The kinetics of recovery of leukocyte number and lymphocyte function following an injection of a single high dose of cyclophosphamide in C3H/HeJ mice. International Journal of Immunopharmacology 11 (1989) 517-527
29. Palcoux J.B., Niaudet P., and Goumy P. Side effects of levamisole in children with nephrosis. Pediatric Nephrology 8 (1994) 263-264
30. Quakyi E.K., Carter P.H., Tsai C.M., and Marti G.E. Immunization with meningococcal membrane-bound lipooligosaccharide accelerates granulocyte recovery and enhances lymphocyte proliferation in myelosuppressde mice. Pathobiology 65 (1997) 26-38
31. Rondinone S.N., Giovanniello O.A., Barrios H.A., and Nota N.R. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice. The Journal of Immunology 130 (1983) 1600-1603
32. Shen R.N., Wu B., Lu L., Kaise H.E., and Broxmeyer H.E. Recombinant human interleukin-1 alpha: a potent bio-immunomodifier in vivo in immunosuppressed mice induced by cyclophosphamide, retroviral infection and surgical stress. In Vivo 8 (1994) 59-63
33. Singh K.P., Gupta R.K., Shau H., and Ray P.K. Effect of ASTA-Z 7575 (INN Maphosphamide) on human lymphokine-activated killer cell induction. Immunopharmacology and Immunotoxicology 15 (1993) 525-538
34. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., and Godfrey D.I. NKT cells-conductors of tumor immunity?. Current Opinion in Immunology 14 (2002) 165-171
35. Sung S.K., Kim M.J., Lee D.H., Choung S.Y., Kim B.K., and Kim H.W. β-Glucan of Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) cooperatively induces tumor necrosis factor-α and interleukin-6 with lipopolysaccharide by binding to dectin-1. International Journal of Medicinal Mushrooms 7 (2005) 193-200
36. Tenbrock K., Muller-Berghaus J., Fuchshuber A., Michalk D., and Querfeld U. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome. Pediatric Nephrology 12 (1998) 459-462
37. Wang Y.Y., Khoo K.H., Chen S.T., Lin C.C., Wong C.H., and Lin C.H. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorganic and Medicinal Chemistry 10 (2002) 1057-1062
38. Weeks B.A., Keisler A.S., Myrvik Q.N., and Warinner J.E. Differential uptake of neutral red by macrophages from three species of estuarine fish. Development and Comparative Immunology 11 (1987) 117-124
39. Wilbanks G.D., Ahn M.C., Beck D.A., and Braun D.P. Tumor cytotoxicity of peritoneal macrophages and peripheral blood monocytes from patients with ovarian, endometrial, and cervical cancer. International Journal of Gynecological Cancer 9 (1999) 427-432
40. Yang Z.B. Effects of pretreatment with lentinan or krestin on antitumor effector cell activities suppressed by cyclophosphamide. Hokkaido Igaku Zasshi 69 (1994) 137-145
41. Yeager A.M., Levin F.C., and Levin J. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cells levels. Journal of Cell Physiology 112 (1982) 222-228
42. Zhang J., Tang Q., Zimmerman-Kordmann M., Reutter W., and Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Science 71 (2002) 623-638
43. Zhu X.L., and Lin Z.B. Effect of Ganoderma lucidum polysaccharides on cytokine-induced killer cells proliferation and cytotoxicity. Acta Pharmacologica Sinica 26 (2005) 1130-1137
44. Zhu X.L., and Lin Z.B. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydrate Polymers 63 (2006) 188-197